Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA02
- Pharmacological subgroupA02B
- Chemical subgroupA02BC
- Chemical substanceA02BC01Omeprazole
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 121 registrations
- ElprazolPharlab Indústria Farmacêutica S.A.
- EupeptCifarma Científica Farmacêutica Ltda
- GastriumAché Laboratórios Farmacêuticos S.A
- LosecBiopas Brasil Produtos Farmaceuticos Ltda
Spain
AEMPS · 112 registrations
At a glance
- ATC code
- A02BC01
- ATC group
- Alimentary tract and metabolism
- Registers
- 10
- Historical lists
- 3
- Registrations
- 507
- With their own page
- 292
- Companies
- 232
All medicines with Omeprazole
Human medicines from every register that match Omeprazole by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
542 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Omeprazole | United States | 20MG | tablet, delayed release | Marketed | Apotex |
| Omeprazole | United States | 20MG | tablet, orally disintegrating, delayed release | Marketed | Dexcel |
| Omeprazole | United States | 10MG, 20MG, 40MG | capsule, delayed rel pellets | Marketed | Xiromed |
| Omeprazole | Canada | 20 MG | Capsule (Delayed-Release) | Marketed | Sanis Health INC |
| Omeprazole | Canada | 20 MG | Capsule (Delayed-Release) | Marketed | Pro Doc Limitee |
| Omeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Not marketed | Laboratoire Riva INC. |
| Omeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Not marketed | Pharmascience INC |
| Omeprazole-20 | Canada | 20 MG | Capsule (Delayed-Release) | Marketed | Sivem Pharmaceuticals Ulc |
| Omeprazole Magnesium | United States | 20MG BASE | tablet, delayed release | Marketed | Hetero Labs LTD III |
| Omeprazole Magnesium | United States | 20MG BASE | capsule, delayed release | Marketed | Dexcel |
| Omeprazole Teva | New Zealand | Cap 10 mg | Funded | ||
| Omeprazole Teva | New Zealand | Cap 20 mg | Funded | ||
| Omeprazole Teva | New Zealand | Cap 40 mg | Funded | ||
| Omeprazole and Sodium BicarbonateCombination | United States | 20MG/PACKET; 1.68GM/PACKET, 40MG/PACKET; 1.68GM/PACKET | for suspension | Marketed | Novitium Pharma |
| Omeprazole and Sodium BicarbonateCombination | United States | 20MG; 1.1GM, 40MG; 1.1GM | capsule | Marketed | Zydus Pharms |
| Omeprazole actavis 10 | New Zealand | Cap 10 mg | Funded | ||
| Omeprazole actavis 20 | New Zealand | Cap 20 mg | Funded | ||
| Omeprazole actavis 40 | New Zealand | Cap 40 mg | Funded | ||
| Apo-Omeprazole | Canada | 20 MG | Capsule (Delayed-Release) | Marketed | Apotex INC |
| Bio-Omeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Marketed | Biomed Pharma |
| Teva-Omeprazole | Canada | 20 MG | Tablet (Delayed-Release) | Marketed | Teva Canada Limited |
| Teva-Omeprazole | Canada | 10 MG | Tablet (Delayed-Release) | Marketed | Teva Canada Limited |
| AG-Omeprazole DR | Canada | 20 MG | Tablet (Delayed-Release) | Authorised | Angita Pharma INC. |
| Jamp-Omeprazole DR | Canada | 20 MG | Tablet (Delayed-Release) | Marketed | Jamp Pharma Corporation |
| Riva-Omeprazole DR | Canada | 20 MG | Tablet (Delayed-Release) | Not marketed | Laboratoire Riva INC. |